Article

The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb <i>E. coli</i> heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination

2023-07-05

Abstract excerpt

The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b2297d3c-cc8f-5d0c-9e15-b274893d7d91
DOI: 10.1101/2023.07.05.547781

Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest

The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb <i>E. coli</i> heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccinationDOI 10.1101/2023.07.05.547781Read

Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell ResponsesSemantic proximity Read

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concernSemantic proximity Read

An Efficient Approach for SARS-CoV-2 Monoclonal Antibody Production via Modified mRNA-LNP ImmunizationSemantic proximity Read

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in miceSemantic proximity Read

Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2Semantic proximity Read

The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity.Semantic proximity Read

Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvantSemantic proximity Read

Oral and Intranasal Immunization with Recombinant Food-Grade Lactococcus Lactis Expressing High Conserved Region of SARS-CoV-2 Spike Protein Triggers Immunity Responses in MiceSemantic proximity Read

Escherichia coli LTB26 mutant enhances immune responses to rotavirus antigen VP8 in a mouse model.Semantic proximity Read

Zebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reactionSemantic proximity Read

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine.Semantic proximity Read

Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.Semantic proximity Read